Wegovy® injection pen, shown upright for product identificationWEGOVY® · INJECTION
BRAND-NAME MEDICATIONRX ONLY

Wegovy®.

Semaglutide injection.
Once-weekly prescription care.

Discuss your health history, goals, and whether Wegovy® may be appropriate for your individual care needs.

WEGOVY® PRICING

Monthly

$1,699/mo

Billed monthly.

Product type
Brand-name prescription
Active ingredient
Semaglutide
Medication class
GLP-1 receptor agonist
Eligibility
Determined by a licensed clinician
Start your evaluation

Prescription only; clinical approval required. An evaluation does not guarantee a particular prescription.

Important safety information

UNDERSTAND YOUR OPTIONS

The details matter.

Explore all weight-management options

Wegovy® is a Novo Nordisk brand of semaglutide. This page focuses on the injectable medicine and pictured single-dose pen, not the oral tablet. The prescribed formulation, strength, and clinical purpose must be confirmed individually.

How Wegovy® works

Semaglutide activates GLP-1 receptors, part of a hormone-signaling system involved in appetite, food intake, and glucose regulation. It also slows stomach emptying. These effects explain both how the medicine acts and why digestive symptoms and interactions with other medicines matter.

Source: Wegovy® clinical pharmacology and prescribing information.

FDA-APPROVED USES / INJECTION

  • Long-term weight management with reduced-calorie eating and increased physical activity in adults with obesity, adults with overweight and a weight-related condition, and adolescents aged 12 or older with obesity.
  • Reduction of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight, with diet and physical activity.
  • Certain adults with noncirrhotic MASH and moderate-to-advanced liver fibrosis (F2–F3). This liver-disease indication has accelerated approval; continued approval may depend on confirmatory evidence of clinical benefit.

Source: Current U.S. indications and limitations of use. Labeled populations do not establish availability through BST Peptides or your personal eligibility.

KNOW THE MEDICINE

Understand your prescription.

A practical overview of Wegovy® injection. Follow the Medication Guide and Instructions for Use supplied with your own prescription.

01 / WEEKLY ROUTINE

How it is used.

Wegovy® injection is used once a week, on the same weekday, at any time of day, with or without food. It is prescribed alongside reduced-calorie eating and increased physical activity.

  • Inject under the skin of the abdomen, thigh, or upper arm; use a different spot for each injection.
  • Treatment starts low and increases gradually to reduce digestive side effects. Your prescriber selects the starting, escalation, and maintenance doses.
  • Do not copy the pictured 1.7 mg strength as your starting dose or increase a dose on your own.
Dosing and administration (PDF)
02 / YOUR DEVICE

One pen. One injection.

The pictured single-dose pen is prefilled and preset, with a hidden needle. One pen supplies one injection; there is no dose to dial. Other Wegovy® devices and tablets have different instructions.

  • Receive training for the exact device dispensed before your first injection. This summary does not replace that training.
  • Do not reuse, share, refill, or try to extract medicine from a used single-dose pen.
  • Place the used pen in an FDA-cleared sharps container immediately after use. Do not put loose pens in household trash or recycling; follow local disposal rules.
Pen use and disposal (PDF)
03 / BEFORE INJECTING

Check before each dose.

Check the prescribed name and strength, expiration date, pen condition, and medicine before using it. Wash your hands and clean the injection site as you were trained.

  • Do not use a pen that is damaged, expired, already used, or contains medicine that is cloudy, colored, or has particles.
  • Keep the cap on until ready to inject. Avoid tender, bruised, red, hard, or scarred skin.
  • With this single-dose device, the second click does not mean the injection is finished. Follow the Instructions for Use and keep pressure until the yellow bar stops moving. Contact your care team if delivery seems incomplete; do not repeat a dose on your own.
Single-dose pen checklist (PDF)
04 / STORAGE & TRAVEL

Keep the pen protected.

For the pictured single-dose pen, refrigerate at 36–46°F (2–8°C) in its original carton to protect it from light. Keep it away from the freezer and out of children’s reach.

  • Before cap removal, the pen may be kept at 46–86°F (8–30°C) in its carton for up to 28 days. Track time out of the refrigerator.
  • Do not use a pen that has frozen, overheated, or exceeded the allowed storage period. Ask the pharmacist about temperature excursions rather than assuming it is safe.
  • Storage rules differ for other presentations. Follow the label on the device actually dispensed to you.
Full storage instructions (PDF)
05 / MISSED INJECTION

Know what to do next.

For one missed weekly injection, the next scheduled dose determines the label’s advice. These instructions do not apply to Wegovy® tablets.

  • If the next dose is more than 48 hours away, take the missed injection as soon as possible. If it is less than 48 hours away, skip it and take the next dose on the usual day.
  • Do not double up. Ask your clinician or pharmacist if timing is unclear.
  • After two or more consecutive missed injections, contact the prescriber before restarting. Restarting at a lower dose and increasing gradually may be necessary to limit digestive side effects.
Missed-dose instructions (PDF)
06 / FOLLOW-UP

Keep care connected.

Your clinician reviews response, tolerability, nutrition, hydration, and other medicines. People with diabetes may need glucose monitoring and adjustments to insulin or sulfonylureas to reduce low-blood-sugar risk.

  • Report persistent vomiting, difficulty drinking fluids, vision changes, or a racing heartbeat at rest.
  • Discuss pregnancy plans, breastfeeding, all medicines, and planned anesthesia or surgery. Do not combine Wegovy® with another semaglutide medicine or GLP-1 receptor agonist.
  • Severe persistent abdominal pain or signs of a serious allergic reaction need urgent assessment. Review the full safety section below; call 911 for a medical emergency.
Medication Guide and warnings (PDF)

HOW IT WORKS

Care comes first.

An online evaluation begins a medical conversation. Treatment and medication selection are never automatic.

  1. STEP 01 / SHARE YOUR HISTORYIllustration of completing an online health intake

    Start with your story.

    Complete the health intake with your medical history, current medicines, previous treatment, and questions for the care team.

  2. STEP 02 / CLINICIAN REVIEWIllustration of a clinician reviewing health information

    Make an informed plan.

    A licensed clinician reviews your information and may request more details or testing. They discuss appropriate options and decide whether to prescribe.

  3. STEP 03 / YOUR NEXT STEPSIllustration of a personalized care plan

    Follow your care plan.

    If prescribed, follow the instructions supplied by your clinician and pharmacy. Confirm follow-up, administration, and any concerns before changing your treatment.

Start your evaluation

BEFORE YOU BEGIN

Know your plan.

Your clinician and pharmacist confirm your specific medication, formulation, instructions, and monitoring needs.

Product-specific care

Do not treat brand names, compounded preparations, or different formulations as interchangeable. Your prescription and pharmacy instructions apply to your particular product.

Current treatment

Share every medication and supplement you use, along with your current dose and last administration. Do not combine, switch, or adjust prescriptions on your own.

Pricing & subscriptions

Review what is included, the billing interval, and any recurring charges at enrollment before agreeing to a plan. Read our Cancellation Policy and Refund Policy.

Availability & eligibility

Services and pharmacy options depend on provider licensure, state requirements, clinical eligibility, and product availability. Read our Compliance page.

READ BEFORE STARTING TREATMENT

Important safety information.

This is a limited summary, not complete prescribing information. Review the full medication information and your pharmacy instructions with your clinician.

A specific brand. A specific prescription.

FDA approval applies to the brand's specific formulations and indications. It does not establish approval or equivalence for compounded preparations or other products containing the same ingredient.

Read the full Wegovy® prescribing information and Medication Guide

BOXED WARNING / THYROID TUMORS

A serious risk to discuss.

Semaglutide caused thyroid tumors in animal studies; human risk is unknown. Do not use it with MTC (medullary thyroid cancer) in your own or family history, MEN 2, or a serious allergy to semaglutide or its ingredients.

Side effects & precautions

Common reported effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, bloating, belching, and reflux. This is not a complete list.

Serious risks include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe digestive symptoms, severe allergic reactions, and low blood sugar, particularly with insulin or sulfonylureas. These medicines are not recommended for severe gastroparesis. Discuss any history of diabetic retinopathy and any vision changes.

Discuss pregnancy and breastfeeding before treatment. The label advises stopping Wegovy® at least two months before a planned pregnancy; contact your clinician promptly if pregnancy occurs. Do not combine it with another semaglutide product or another GLP-1 receptor agonist. Tell anesthesia teams about its use before procedures.

Delayed stomach emptying can increase aspiration risk during anesthesia or deep sedation. Tell every procedural care team about treatment; they determine any required adjustments.

Seek urgent care for severe persistent abdominal pain or signs of a serious allergic reaction. Call 911 for a medical emergency.

Full reference: Wegovy® prescribing information and Medication Guide. Follow the information for the exact product prescribed to you.

Wegovy® is a registered trademark of Novo Nordisk. BST Peptides is not the manufacturer.

COMMON QUESTIONS

A little more clarity.

Questions about your account?
Contact BST Peptides support

Who decides if Wegovy® is appropriate for me?

A licensed clinician makes that decision after reviewing your health information. Completing an intake or viewing a product page does not guarantee treatment or a particular prescription.

How much does Wegovy® cost?

Wegovy® is $1,699 per month with monthly billing. Review the offer, what is included, and billing terms at enrollment. Our Cancellation Policy explains renewals and cancellation.

Is this the same as a compounded medication?

No. Compounded preparations are not FDA-approved generics or equivalents of brand-name medicines. A clinician and pharmacist must assess the specific product and your medical needs.

Is Wegovy® the same as Ozempic®?

They share semaglutide, but their approved uses, dose options, and devices differ. They are not automatically interchangeable and should not be taken together. A clinician must manage any switch. Manufacturer reference.

Does this page cover Wegovy® tablets or every pen strength?

No. The image and storage example describe a single-dose injection pen. Oral tablets and other presentations have their own labeling. Availability through BST Peptides and the exact product prescribed are confirmed separately. Manufacturer reference.

What if the pen seems not to deliver the full injection?

Do not give yourself another injection to make up an uncertain dose. Contact the prescriber or pharmacist for instructions. For the pictured pen, keep it against the skin until the yellow bar stops moving; the second click alone does not signal completion. Device training and the supplied Instructions for Use are essential. Manufacturer reference.

How soon should I expect results?

There is no guaranteed amount or timeline of weight change. Response varies, and dose escalation is gradual. Your clinician reviews progress, side effects, nutrition, activity, and whether continuing or adjusting treatment is appropriate. Manufacturer reference.

Can I switch from another medication?

Share your current prescription, dose, and treatment history with your clinician. Do not switch, combine, or adjust medications without their guidance.

Where can I review the full safety information?

Review the safety section above and the Wegovy® prescribing information and Medication Guide. Ask your clinician and dispensing pharmacist about instructions for your specific prescription.

OFFICIAL PRODUCT INFORMATION

Read the source.

Educational information checked against manufacturer sources on October 22, 2026. This is not a substitute for the full labeling, clinical advice, or device training.

Manufacturer programs, prices, and other product presentations are not promises about BST Peptides’ service. Confirm your medication, device, cost, and ongoing care before enrollment.

YOUR NEXT STEP

Start a conversation.
Not a commitment to medication.

Share your health history and care goals with a licensed clinician.

Start your evaluation

Prescription only. Subject to clinical approval.